Composition for restraining muscle content reducing
A composition and muscle mass technology, applied in the direction of drug combination, active ingredients of anhydride/acid/halide, medical raw materials derived from molluscs, etc., can solve problems such as loss of appetite, accompanied by pain, and no treatment method found, to achieve The effect of suppressing the loss of muscle mass and the reduction of vitality
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2015-12-09
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a composition effective in suppressing the decrease in muscle mass seen in cachexia (cachexia) caused by aging or cancer. Background technique
[0002] People who have dyscrasias due to aging, cancer, etc. have a phenomenon called sarcopenia, in which muscle mass itself decreases, in addition to a decrease in vitality. Sarcopenia is a decrease in physical function or QOL (Quality Of Life), and sometimes leads to death.
[0003] The decline in QOL due to the decrease in muscle mass (sarcopenia) in the global aging of human beings is a problem that should be solved on a global scale. Hot topics in research in the field of nutrition, mitigation.
[0004] Here, dyscrasia is a complex metabolic syndrome in which a decrease in muscle mass (sarcopenia) is accompanied by a loss of fat irrespective of fat loss due to a disease, and a phenomenon of weight loss is characteristic of dyscrasia. Specifically, in addition to reduci...
Examples
Embodiment
[0053] In this example, cancer patients (patients whose prognosis was declared less than 6 months) who resorted to loss of appetite were divided into the following four groups (groups 1G-4G) by random (envelope method) for the experiment.
[0054] 1G is a group provided with only general food. 2G is a group in which capsules containing 300 mg of soft-shelled turtle powder were given three times a day in addition to general food. 3G is a group in which capsules containing 50 mg of soft-shelled turtle powder, 100 mg of soft-shelled turtle egg powder, and 100 mg of soft-shelled turtle oil were provided three times a day in addition to general food. 4G is to provide 50mg of soft-shelled turtle powder, 100mg of soft-shelled turtle egg powder, 100mg of soft-shelled turtle oil, and 50mg of oyster powder (taurine content: 5mg, zinc content: 250ppm, glycogen content: 38mg) three times a day in addition to general food. ) of capsules.
[0055] For the number of samples, for Figures ...